Do community pharmacists in Nepal have a role in adverse drug reaction reporting systems?

被引:14
作者
Bhuvan, K. C. [1 ]
Alrasheedy, Alian A. [2 ]
Ibrahim, Mohamed Izham Mohamed [3 ]
机构
[1] Sankalpa Fdn Pvt Ltd, Sociopharmacol Div, Travel Med, Clin Pharm, Pokhara, Nepal
[2] Univ Sains Malaysia, Sch Pharmaceut Sci, Discipline Social & Adm Pharm, Gelugor, Penang, India
[3] Qatar Univ, Coll Pharm, Res & Grad Studies Affair, Doha, Qatar
来源
AUSTRALASIAN MEDICAL JOURNAL | 2013年 / 6卷 / 02期
关键词
Community Pharmacy; Adverse Drug Reaction; Pharmacist; Nepal;
D O I
10.4066/AMJ.2013.1544
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Community pharmacies in Nepal serve both rural and urban populations and are an integral part of the Nepalese healthcare system. These community pharmacies are run by non-pharmacist professionals with orientation training on pharmacology and drug dispensing. Graduate pharmacists' involvement in community pharmacy will help with patient counselling, dispensing of medication and promotion of safe and appropriate medicine use. Nepal has an organised pharmacovigilance system which incorporates adverse drug reaction (ADRs) from hospitals and tertiary care centres but not from the community. Involvement of pharmacists in community pharmacy will help in ADR reporting and, monitoring at community level and will help in promoting medication safety in the community. This article describes the community pharmacovigilance program in Nepal and the prospects for community pharmacists.
引用
收藏
页码:100 / 103
页数:4
相关论文
共 12 条
  • [1] [Anonymous], 2005, DBN, V16, P6
  • [2] [Anonymous], NPSA NPSS WORKSH PAR
  • [3] [Anonymous], UN DEV PROGR COUNTR
  • [4] Creatinine Clearance Calculator, CREATININE CLEARANCE
  • [5] Jha N, 2012, AUSTRALAS MED J, V5, P268, DOI [10.4066/AMJ.2012.1142, 10.4066/AMJ.2012.1142.]
  • [6] KC B, 2011, AJPE, V75
  • [7] Nepal Pharmacy Council Newsletter, 2007, NPC NEWSLETTER, V2, P1
  • [8] Paalman M., 2004, MACROECONOMICS HLTH
  • [9] Subish P, 2008, J CLIN DIAGN RES, V2, P905
  • [10] Subish P, 2008, PAK J PHARM SCI, V21, P565